RELMADA THERAPEUTICS, INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
RELMADA THERAPEUTICS, INC. (RLMD) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $7.49 million as of 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-03-19
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $7.49M.
- 2024-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $16.29M.
- 2024-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $32.00M.
- 2024-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $39.20M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount as first filed |
|---|---|---|
| 2025-12-31 | $7.49M 10-K · filed 2026-03-19 | |
| 2024-12-31 | $16.29M 10-K · filed 2025-03-27 | |
| 2024-09-30 | $32.00M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $39.20M 10-Q · filed 2024-08-07 | |
| 2022-09-30 | $6.70M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $7.70M 10-Q · filed 2022-08-11 | |
| 2021-12-31 | $12.40M 10-K · filed 2022-03-25 | |
| 2020-12-31 | $53.50M 10-K · filed 2021-03-24 | |
| 2020-06-30 | $103.00K 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $116.00K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $54.45M 10-KT · filed 2020-03-26 | |
| 2019-06-30 | $3.38M 8-K · filed 2019-10-18 | |
| 2018-03-31 | $81.00K 10-Q · filed 2018-05-14 | |
| 2017-09-30 | $5.90K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $0.00 10-Q · filed 2018-05-14 | $391.29K 10-K · filed 2017-09-28 |
| 2016-06-30 | $1.26M 10-K · filed 2016-09-09 | |
| 2016-03-31 | $2.19M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $2.35M 10-Q · filed 2016-02-05 | |
| 2015-09-30 | $2.44M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $2.50M 10-K · filed 2015-09-11 | |
| 2015-03-31 | $3.13M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $2.09M 10-Q · filed 2015-02-13 | |
| 2014-09-30 | $1.86M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $1.76M 10-K · filed 2015-09-11 | |
| 2013-12-31 | $589.50K 10-K · filed 2015-09-11 | |
| 2012-12-31 | $0.00 10-K · filed 2015-09-11 | $68.60K 8-K · filed 2014-05-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |